Preliminary study on the effects of combined hydrolytic enzyme agents on mouse Krebs-2 carcinoma.
D000818:Animals; D002287:Carcinoma, Krebs 2 / Q000188:drug therapy* / Q000401:mortality; D002452:Cell Count; D002918:Chymotrypsin / Q000627:therapeutic use; D003851:Deoxyribonucleases / Q000627:therapeutic use*; D010450:Endopeptidases / Q000627:therapeutic use*; D005260:Female; D007274:Injections, Intraperitoneal; D051379:Mice; D008813:Mice, Inbred ICR; D010435:Pepsinogens / Q000627:therapeutic use*; D012260:Ribonucleases / Q000627:therapeutic use*; D014357:Trypsin / Q000627:therapeutic use
D010435:Pepsinogens; D003851:Deoxyribonucleases; D012260:Ribonucleases; D010450:Endopeptidases; D002918:Chymotrypsin; D014357:Trypsin